Literature DB >> 19023897

Validation of interactive voice response system administration of the Short Inflammatory Bowel Disease Questionnaire.

Manuel Y Lam1, Hang Lee, Renee Bright, Joshua R Korzenik, Bruce E Sands.   

Abstract

BACKGROUND: The Short Inflammatory Bowel Disease Questionnaire (SIBDQ) is a written, self-administered instrument measuring quality of life in IBD. We assessed the validity of an interactive voice response system (IVRS) as a new mode of administering the SIBDQ.
METHODS: An IVRS was designed using prerecorded questions to collect data via touchtone telephone. Subjects with Crohn's disease (CD) or ulcerative colitis (UC) were randomized into 2 groups with different orders of administration: written, self-administered followed by IVRS (S-I) or IVRS followed by written, self-administered (I-S). Half of the S-I group was also randomized to receive a second IVRS. Sixty-four subjects were studied: 30 in S-I, 34 in I-S.
RESULTS: The mean SIBDQ scores were not different between written and IVRS modes (P = 0.26) with r = 0.93. IVRS scores were lower in active than inactive CD (36.1 +/- 9.6 versus 54.7 +/- 8.6, P < 0.001) and lower in active than inactive UC (40.8 +/- 9.6 versus 59.8 +/- 10.0, P < 0.001). Mean scores correlated highly with disease activity indices, and were not different between first and second IVRS administrations (P = 0.85) with r = 0.92. IVRS had excellent internal consistency (Cronbach alpha = 0.90).
CONCLUSIONS: IVRS administration of the SIBDQ yields results similar to written self-administration, with excellent procedural validity, test-retest reliability, and internal consistency.

Entities:  

Mesh:

Year:  2009        PMID: 19023897     DOI: 10.1002/ibd.20803

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  12 in total

1.  Interactive voice response technology: a tool for improving healthcare.

Authors:  Margaret Ross Kraft; Ida Androwich
Journal:  NI 2012 (2012)       Date:  2012-06-23

2.  Recall accuracy of weekly automated surveys of health care utilization and infectious disease symptoms among infants over the first year of life.

Authors:  Catherine Ley; Lauren Willis; Maria de la Luz Sanchez; Julie Parsonnet
Journal:  PLoS One       Date:  2019-12-17       Impact factor: 3.240

3.  Patient perception of chronic illness care in a large inflammatory bowel disease cohort.

Authors:  Rachel L Randell; Millie D Long; Christopher F Martin; Robert S Sandler; Wenli Chen; Kristen Anton; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

Review 4.  Interactive voice response technology for symptom monitoring and as an adjunct to the treatment of chronic pain.

Authors:  Gregory Lieberman; Magdalena R Naylor
Journal:  Transl Behav Med       Date:  2012-03       Impact factor: 3.046

5.  The Development of an Interactive Voice Response Survey for Noncommunicable Disease Risk Factor Estimation: Technical Assessment and Cognitive Testing.

Authors:  Dustin G Gibson; Brooke A Farrenkopf; Amanda Pereira; Alain B Labrique; George William Pariyo
Journal:  J Med Internet Res       Date:  2017-05-05       Impact factor: 5.428

Review 6.  New Considerations in the Design of Clinical Trials for Bone Metastases.

Authors:  Madeline Lemke; Karen Lien; Liang Zeng; Marko Popovic; Michelle Zhou; Julia Digiovanni; Emily Chen; Edward Chow
Journal:  World J Oncol       Date:  2012-02-19

Review 7.  Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties.

Authors:  Xin-Lin Chen; Liang-Huan Zhong; Yi Wen; Tian-Wen Liu; Xiao-Ying Li; Zheng-Kun Hou; Yue Hu; Chuan-Wei Mo; Feng-Bin Liu
Journal:  Health Qual Life Outcomes       Date:  2017-09-15       Impact factor: 3.186

Review 8.  Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013.

Authors:  Willie Muehlhausen; Helen Doll; Nuz Quadri; Bethany Fordham; Paul O'Donohoe; Nijda Dogar; Diane J Wild
Journal:  Health Qual Life Outcomes       Date:  2015-10-07       Impact factor: 3.186

9.  The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamine.

Authors:  Aaron Yarlas; Linnette Yen; Paul Hodgkins
Journal:  Qual Life Res       Date:  2014-09-06       Impact factor: 4.147

10.  Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients.

Authors:  Yu-Feng Xing; Chun-Shan Wei; Tian-Ran Zhou; Dan-Ping Huang; Wei-Chao Zhong; Bin Chen; Hua Jin; Xiao-Yu Hu; Zhi-Yun Yang; Qing He; Kai-Ping Jiang; Jun-Min Jiang; Zhen-Bin Hu; Xin Deng; Fan Yang; Feng-Yi Li; Gang Zhao; Li-Chun Wang; Yu-Qiang Mi; Zuo-Jiong Gong; Peng Guo; Jian-Hua Wu; Wei-Qun Shi; Hong-Zhi Yang; Da-Qiao Zhou; Guang-Dong Tong
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.